An end to Finger Pricking for Diabetics
About 10% of the US is diabetic, that doesn’t sound like a lot until you realize how many people there are in the US (roughly 311 million and counting). Think about it like this, every 7 seconds (roughly) a child is born. With that statistic every minute and 10 seconds leads to another person with diabetes. By the time you finish reading this, about two people in the US will be diagnosed with diabetes.
As I mentioned diabetes is it’s own brand of hell, pokes and prods with needles and testing blood sugar can get tedious and painful, fast. Speaking of which (see how I did that) the constant finger pricks to test blood glucose levels is the number one complaint amongst diabetics, but now that is about to change.
Researchers have developed a way to use a laser to measure people’s blood sugar, and, with more work to shrink the laser system to a portable size, the technique could allow diabetics to check their blood sugar levels without pricking themselves to draw blood.
“We are working hard to turn engineering solutions into useful tools for people to use in their daily lives,” said Claire Gmachl, the Eugene Higgins Professor of Electrical Engineering and the project’s senior researcher. “With this work we hope to improve the lives of many diabetes sufferers who depend on frequent blood glucose monitoring.”
The researchers measured blood sugar by directing their specialized laser at a person’s palm. The laser passes through the skin cells, without causing damage, and is partially absorbed by the sugar molecules in the patient’s body. The researchers found that they can use the amount of absorption to measure the level of blood sugar.
The accuracy of the method was what surprised the team most. Glucose monitors are required to produce a blood-sugar reading within 20 percent of the patient’s actual level; even an early version of the system met that standard. Think about it, a 20% error is a huge range for your blood sugar levels when testing. The current version is 84 percent accurate and that is only the beginning.
“It works now but we are still trying to improve it,” said Liakat, a graduate student in electrical engineering.
When the team first started, the laser was an experimental setup that filled up a moderate-sized workbench. It also needed an elaborate cooling system to work. Gmachl said the researchers have solved the cooling problem, so the laser works at room temperature. The next step is to shrink it so it can become feasible to mass produce.
“This summer, we are working to get the system on a mobile platform to take it places such as clinics to get more measurements,” Liakat said. “We are looking for a larger dataset of measurements to work with.”
The key to the system is the infrared laser’s frequency. What our eyes perceive as color is created by light’s frequency (the number of light waves that pass a point in a certain time, not to be confused with amplitude, which is the height of those waves). Red is the lowest frequency of light that humans normally can see, and infrared’s frequency is below that level. Current medical devices often use the “near-infrared,” which is just beyond what the eye can see. This frequency is not blocked by water, so it can be used in the body, which is largely made up of water. Unfortunately for the team, it does interact with many acids and chemicals in the skin, so it makes it impractical to use for detecting blood sugar.
Mid-infrared light (or an even lower frequency), is not as much affected by these other chemicals, so it works well for blood sugar. But mid-infrared light is difficult to harness with standard lasers. It also requires relatively high power and stability to penetrate the skin and scatter off bodily fluid. (The target is not the blood but fluid called dermal interstitial fluid, which has a strong correlation with blood sugar, which is also why diabetics also have to deal with swelling.)
The breakthrough came from the use of a new type of device that is particularly adept at producing mid-infrared frequencies — a quantum cascade laser (yes, it is as cool as the name makes it sound).
In many lasers, the frequency of the beam depends on the material that makes up the laser — a helium-neon laser, for example, produces a certain frequency band of light. But in a quantum cascade laser, in which electrons pass through a “cascade” of semiconductor layers, the beam can be set to one of a number of different frequencies. The ability to specify the frequency allowed the researchers to produce a laser in the mid-infrared region. Recent improvements in quantum cascade lasers also provided for increased power and stability needed to penetrate the skin.
To conduct their experiment, the researchers used the laser to measure the blood sugar of three healthy people before and after they each ate 20 jellybeans, which raise blood sugar levels. The researchers also checked the measurements with a finger-prick test. They conducted the measurements repeatedly over several weeks. It sounds simple enough, but even the same person can have different blood glucose spikes after consuming the same food, so measuring several times over several weeks allowed the researchers to control for that variation.
The researchers said their results indicated that the laser measurements readings produced average errors somewhat larger than the standard blood sugar monitors, but remained within the clinical requirement for accuracy. Another bonus, this technology could be used for more than just blood sugar:
“Because the quantum cascade laser can be designed to emit light across a very wide wavelength range, its usability is not just for glucose detection, but could conceivably be used for other medical sensing and monitoring applications,” Gmachl said.
While we probably won’t see hand held quantum cascade laser blood glucose testing for a little while, this does give an exciting new way to test blood glucose levels and hopefully end the tyranny of finger pricking for diabetics everywhere.
Did you hear the cheers? Because, I think I did.
Liakat S, Bors KA, Xu L, Woods CM, Doyle J, & Gmachl CF (2014). Noninvasive in vivo glucose sensing on human subjects using mid-infrared light. Biomedical optics express, 5 (7), 2397-404 PMID: 25071973
But enough about us, what about you?